|
Kuhn, Deborah J; Smith, David M; Pross, Seth et al. (2003) Overexpression of interleukin-2 receptor alpha in a human squamous cell carcinoma of the head and neck cell line is associated with increased proliferation, drug resistance, and transforming ability. J Cell Biochem 89:824-36
|
|
Whiteside, Theresa L; Gambotto, Andrea; Albers, Andreas et al. (2002) Human tumor-derived genomic DNA transduced into a recipient cell induces tumor-specific immune responses ex vivo. Proc Natl Acad Sci U S A 99:9415-20
|
|
Reichert, T E; Nagashima, S; Kashii, Y et al. (2000) Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression. Oncogene 19:514-25
|
|
Reichert, T E; Kashii, Y; Stanson, J et al. (1999) The role of endogenous interleukin-2 in proliferation of human carcinoma cell lines. Br J Cancer 81:822-31
|
|
Kashii, Y; Giorda, R; Herberman, R B et al. (1999) Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J Immunol 163:5358-66
|
|
Nagashima, S; Mailliard, R; Kashii, Y et al. (1998) Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo. Blood 91:3850-61
|
|
Lang, S; Vujanovic, N L; Wollenberg, B et al. (1998) Absence of B7.1-CD28/CTLA-4-mediated co-stimulation in human NK cells. Eur J Immunol 28:780-6
|
|
Whiteside, T L; Sung, M W; Nagashima, S et al. (1998) Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo. Clin Cancer Res 4:1135-45
|
|
Reichert, T E; Watkins, S; Stanson, J et al. (1998) Endogenous IL-2 in cancer cells: a marker of cellular proliferation. J Histochem Cytochem 46:603-11
|
|
Reichert, T E; Rabinowich, H; Johnson, J T et al. (1998) Mechanisms responsible for signaling and functional defects. J Immunother 21:295-306
|
Showing the most recent 10 out of 21 publications
